BIOMAT Database Logo BIOMAT Database Logo

[Heparin activity and plasmatic lipoproteins in arteriosclerosis]. 1957

F GUTIERREZ VALLEJO, and R INFANTE MIRANDA

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses

Related Publications

F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Influence of heparin on plasmatic lipoproteins in patients with coronary arteriosclerosis].
January 1969, Studii si cercetari de medicina interna,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Post-heparin plasmatic lipolytic activity (PHLA) and related pre-heparin plasmatic inhibitor in liver diseases].
October 1967, Rivista critica di clinica medica,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Lipoproteins and arteriosclerosis].
November 1985, Medicina clinica,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Lipoproteins and arteriosclerosis].
July 1980, Nihon rinsho. Japanese journal of clinical medicine,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Heparin activity of the plasma in arteriosclerosis].
December 1954, Revista clinica espanola,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Lipoproteins and coronary arteriosclerosis].
September 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Serum lipoproteins and arteriosclerosis].
August 1983, Nihon rinsho. Japanese journal of clinical medicine,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Heparin and arteriosclerosis].
June 1953, France Medecine,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Arteriosclerosis and heparin].
January 1962, Angiologia,
F GUTIERREZ VALLEJO, and R INFANTE MIRANDA
[Immunological reactions to lipoproteins and heparin in young men with a hereditary tendency to arteriosclerosis].
January 1982, Kardiologiia,
Copied contents to your clipboard!